Chemotherapy-induced peripheral neuropathy (CIPN) is a common and potentially dose-limiting adverse effect of platinum-based chemotherapies that features pain and sensory deficits in the periphery.
Depression may be an overlooked factor in cancer outcomes, according to a large SEER-Medicare analysis of more than 265,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results